To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer
Status:
Terminated
Trial end date:
2018-11-20
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy and safety of i.v. infusion for 24-hour of
SCB01A in subjects with squamous cell carcinoma of head and neck who have failed previous
platinum based therapies.